Evidence against hypercoagulability in coronary artery disease

Area of Science:

• Cardiovascular Medicine
• Hematology
• Thrombosis Research

Background:

• Elevated plasma clotting factors in coronary artery disease (CAD) suggest a hypercoagulable state.
• This interpretation is challenged by the lack of direct evidence for altered coagulation mechanisms.
• Understanding the prothrombotic state in CAD is crucial for effective treatment strategies.

Purpose of the Study:

• To investigate the overall coagulation status in patients with CAD.
• To compare coagulation and platelet reactivity between CAD patients and healthy controls.
• To determine the relationship between coagulation status, platelet reactivity, and CAD severity.

Main Methods:

• Utilized a dynamic global test to assess coagulation status in 761 CAD patients undergoing coronary artery bypass grafting.
• Compared coagulation status with 100 healthy matched controls.
• Measured platelet reactivity to shear-stress using identical, non-anticoagulated blood samples.

Main Results:

• Overall coagulation status did not significantly differ between CAD patients and controls.
• Coagulation status showed no correlation with the severity of coronary atherosclerosis.
• Platelet reactivities were significantly increased in patients with multi-vessel disease compared to single-vessel disease.

Conclusions:

• The procoagulant state in CAD is not due to a hypercoagulable mechanism.
• Enhanced platelet reactivity, rather than coagulation imbalance, underlies the prothrombotic state in CAD.
• Findings suggest a shift in focus from coagulation factors to platelet function in understanding CAD pathophysiology.